sartorius ag
sartorius ag: cfo joerg pfirrmann has decided to leave sartorius by mid - 2017 .
sartorius signs a cooperation agreement with metrohm schweiz ag for marketing sartorius mechatronics laboratory equipment in switzerland .
oddo seydler bank ag, m. m. warburg & co (ag & co .) kgaa
sartorius is converted to a publically traded company, the
sartorius - werke ag
, with four segments .
srt3. xe company profile & executives - sartorius ag pfd. - wall street journal
srt3. de: summary for sartorius ag vzo o. n. - yahoo finance
categories: europe value analsysis yahoo financeclick here to see latest analysis capitalcube gives sartorius ag a score of 53. our analysis is based on comparing sartorius ag with the following peers – mut ag, stratec biomedical ag, orthofix international nv and tecan group ag (m7u - de, sbs - de, ofx - de and tecn - ch). investment outlook sartorius ag has a fundamental score of 53 and... read more (read more... )
the publically - traded sartorius - ag is converted to a gmbh (a limited liability company) .
after his brother wilhelm passed away, erich sartorius takes over at the helm of the sartorius - werke ag as well as the membrane filter company, which is refounded as a partnership limited by shares (kg) and incorporated into the sartorius ag .
sartorius stedim biotech gmbh acquires swiss - based wave biotech ag, a leading supplier of single - use bioreactors .
with the genius analytical balance, sartorius ag wins the innovation award of the german economy in the category of medium - sized companies .
sartorius ag will publish its first - half 2018 results on tuesday, july 24, 2018 at 7 a. m. cet. more
categories: yahoo financeget free summary analysis sartorius ag reports financial results for the quarter ended june 30, 2017. we analyze the earnings along side the following peers of sartorius ag – stratec biomedical ag (sbs - de) that have also reported for this period. highlights summary numbers: revenues of eur 361 million, net earnings of eur 25. 20 million. gross... read more (read more... )
the legal corporate structure of sartorius ag is transformed into a holding company organization: the annual shareholders’ meeting resolves to run the operational mechatronics business, conducted so far within sartorius ag, as an independent entity below the holding level. this move further enhances the company’s ability to generate dividends and increases the transparency of its corporate structure .
the company sartorius ag has announced a stock split at a ratio of 1: 4. more information about this transaction is available on the company 's website under urltoken .
tibor péterfi. from chambers and maskar (1953). image courtesy of s. karger, ag, basel .
sartorius acquires boekels, market leader in quality control for the processing industry and in metal detection (now sartorius aachen) .
sartorius ag is a germany - based supplier of pharmaceutical and laboratory equipment. it operates through two segments: bioprocess solutions and lab products and services. the bioprocess solutions segment offers integrated sol
the following disclaimer and information has been prepared by voltabox ag (the “issuer”) for the purpose of publishing the securities prospectus by the issuer. deutsche boerse ag does not assume any responsibility for the content of the issuer 's disclaimer and information .
the group companies are united under the roof of sartorius ag, which is listed on the frankfurt stock exchange and holds the majority stake in sartorius stedim biotech s. a. quoted on the paris stock exchange, this subgroup is comprised mainly of the bioprocess solutions division .
sartorius, through its subgroup sartorius stedim biotech, acquires the majority stake in the u. s. startup allpure technologies llc; the allpure product range complements sartorius’ single - use - portfolio for the biopharmaceutical industry .
sartorius acquires the uk company tap biosystems group plc through its subgroup sartorius stedim biotech; this acquisition further expands sartorius’ bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development .
on monday, sartorius ag (srtx: ger) closed at 119. 25, - 11. 34% below its 52 - week high of 134. 50, set on may 25, 2018 .
the mechatronics and biotechnology division of sartorius holds festive inauguration ceremonies for its sartorius india campus in bangalore with a floor area of 10, 000 square meters .
brief - sartorius q1 group relevant net profit up at eur 37. 2 mln
alliance with schmidt + haentsch: sartorius markets the brixxus series of laboratory refractometers .
a new sartorius knowledge center is inaugurated in bangalore, india (photo) .
glassdoor gives you an inside look at what it' s like to work at sartorius, including salaries, reviews, office photos, and more. this is the sartorius company profile. all content is posted anonymously by employees working at sartorius .
the mechatronics and biotechnology division of sartorius holds inauguration ceremonies for its sartorius india campus in bangalore with a floor area of 10, 000 square meters (photo) .
sartorius acquires toha plast gmbh and strengthens its position in plastics technology for biopharmaceutical disposables .
sartorius receives the renowned frost & sullivan award for outstanding innovation in biotech product differentiation .
sartorius uses the first machine for automatic manufacture of synthetic membrane filters. as part of its global expansion, sartorius establishes a growing number of international subsidiaries and sales offices .
the goettingen
university mechanician
florenz sartorius founds the fine - precision machine company called
feinmechanische werkstatt f. sartorius
and starts producing short - beam analytical balances .
foundation of lonza ag electricity works in gampel, valais (switzerland), on the banks of river lonza. the electricity was used to manufacture calcium carbide and acetylene .
the companies of august becker (goettingen) and ludwig tesdorpf (stuttgart) manufacture products completementary to sartorius’ portfolio. through the acquisition of these companies sartorius adds microtomes and other instruments for microscopy, astronomical and geodetical devices as well as telescopes to the product line. the companies are integrated into the sartorius firm under the new name
f. sartorius, vereinigte werkstätten fuer wissenschaftliche instrumente von f. sartorius, a. becker und ludwig tesdorpf
. florence sartorius involves his sons wilhelm, erich and julius into the growing family enterprise .
sartorius’ first electromagnetic forcecompensating (emc) balance, the elektrono 1, enters commercial production .
© copyright 2013. all rights reserved. sartorius (thailand) co. , ltd .
i applied online. i interviewed at sartorius (cambridge, ma) in january 2017 .
sartorius said essen expects to achieve sales revenues in the region of $ 60 million in 2017 .
sartorius buys a 100% stake in application specialist omnimark instrument corporation based in arizona, usa .
sartorius builds the first electronic precision and analytical balances. the resulting boom in orders leads to the founding of numerous foreign subsidiaries, and contributes decisively to the significance of the sartorius group today .
north k. congenital myopathies. engel ag, franzini - armstrong c, eds. myology. 3rd ed. new york, ny: mcgraw hill; 2004. 1473 - 1533 .
sartorius ag is a germany - based supplier of pharmaceutical and laboratory equipment. it operates through two segments: bioprocess solutions and lab products and services. the bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, ... (more )
the brochure gives an overview about sartorius' two business divisions, corporate values, people and sites .
alliance with tews elektronik: agreement signed for exclusive marketing and servicing of microwave resonance analyzers by sartorius .
on the sartorius campus in goettingen production starts at the new building for the manufacture of lab instruments .
for over 140 years sartorius has been accomplishing in utilizing the latest scientific expertise to manufacture innovative products. it all started at the university of goettingen when former “university mechanician” florenz sartorius laid the cornerstone for the company. in 1870, sartorius went into business by setting up his precision mechanical workshop ,
feinmechanische werkstatt f. sartorius .
his pioneering invention – the short - beam analytical balance – revolutionized work in research labs .
* q1 sartorius increased its sales revenue by 11. 4% (reported: 6. 3% )
founded in 1870 in goettingen, germany, sartorius today is a joint stock company with production facilities, sales subsidiaries and local commercial agencies in more than 110 countries. sartorius currently employs more than 6, 200 people globally, of which approximately 38% are based in germany. in fiscal 2015, the sartorius group earned sales revenue of 1, 114. 8 million euros. sartorius has been listed in the tecdax technology index since 2012 .
in 1927, together with the chemistry nobel prize laureate richard zsigmondy, sartorius established the limited liability company “membranfiltergesellschaft mbh”. the membranes invented by zsigmondy were the basis for the development of membrane filtration – and for today’s bioprocess business at sartorius. even to this day, weighing and filtration are the core technologies within sartorius’s wide product array .
sartorius moves up to the tecdax, the leading index of the 30 largest and most liquid german technology stocks .
michael melingo, member of the group executive committee and president of the lab products & services division at sartorius .
sartorius expects its employees to think outside the box, show initiative and be willing to take responsibility. to foster this climate, managers at sartorius are obligated to create the basic conditions for their teams to perform at their best .
last month sartorius reported joining the european molecular biology laboratory (embl) corporate partnership program for training and science education .
brief - sartorius to propose dividend of eur 0. 51 per preference share and eur 0. 50 per ordinary share
sartorius continues to expand its worldwide production capacity. at its sites in goettingen and guxhagen, germany, and in yauco, puerto rico, sartorius is scheduled to move into new industrial building complexes and to complete its facility upgrades in 2012 .
our corporate philosophy of “turning science into solutions“ stands for what sartorius has been accomplishing for over 140 years day in, day out: utilizing the latest scientific expertise to manufacture innovative products. it all started at the university of goettingen when former “university mechanician” florenz sartorius laid the cornerstone for the company. in 1870, sartorius went into business by setting up his precision mechanical workshop ,
feinmechanische werkstatt f. sartorius .
his pioneering invention – the short - beam analytical balance – revolutionized work in research labs. in 1927, together with the chemistry nobel prize laureate richard zsigmondy, sartorius established the limited liability company “membranfiltergesellschaft mbh”. the membranes invented by zsigmondy were the basis for the development of membrane filtration – and for today’s bioprocess business at sartorius. even to this day, weighing and filtration are the core technologies within sartorius’s wide product array .
in 1898, sartorius establishes a new production site on weender landstrasse in goettingen which will remain the company’s headquarters until 2018 .
in stonehouse, uk sartorius expands its site, doubling its local production capacities for single - use plastic products for laboratories .
the annual and consolidated financial statements prepared by the executive board for fiscal 2016 and the management report of sartorius ag were reviewed by the independent auditing company kpmg wirtschaftsprüfungsgesellschaft, based in hanover, germany. this company had been commissioned by the audit committee of the supervisory board pursuant to the resolution passed at the annual shareholders’ meeting on april 7, 2016. the independent auditors issued an unqualified audit certificate. they attended the audit committee meeting on february 20, 2017, and the supervisory board meeting on february 21, 2017, and reported on the essential results of their audits. sufficient time was allotted for discussion of all issues with the auditors. written information and audit reports had been sent to all supervisory board members on time and were discussed in detail during the meetings mentioned. on the basis of its own examination of the annual sartorius ag and consolidated financial statements, the sartorius ag management report and the group management report, the supervisory board concurred with the results of the audit conducted by kpmg and, at the meeting on february 21, 2017, endorsed the financial statements of sartorius ag and the group on recommendation by the audit committee. the annual financial statements were thus approved. the supervisory board and the executive board will submit a proposal at the annual shareholders’ meeting on april 6, 2017, to pay dividends of €0. 46 per preference share and €0. 45 per ordinary share from the retained profit to the shareholders .
engel ag, gomez mr, groover rv. multicore disease. a recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. mayo clin proc. 1971 oct. 46 (10): 666 - 81. [ medline ] .
sartorius ag is an international laboratory and process technology provider for the biotech, pharmaceutical, and food industries. it operates through the bioprocess solutions and lab products and services divisions. the bioprocess solutions division focuses on the major areas of activity of filtration, fluid management, fermentation, and purification. the lab products and services division focuses on lab balances, pipettes, and laboratory water purification systems. the company was founded by florence sartorius sr. in 1870 and is headquartered in goettingen, germany .
together with its partner zufall logistics, sartorius opens a new logistics center at the siekanger distribution zone in goettingen, germany. from this center, laboratory and process products are shipped out worldwide and all goettingen - based sartorius sites are supplied (photo) .
sartorius stedim biotech extends its product portfolio for viral safety in the manufacture of biopharmaceuticals by forming an alliance with bayer technology services .
lonza and sartorius stedim biotech enter collaboration, supply and distribution agreement in the field of cell culture media, in which sartorius stedim biotech assumes global sales and marketing of media and buffer solutions for biopharmaceutical manufacturing. lonza will continue to manufacture all media products .
at sartorius, experts can continuously expand their skills and careers, for example, by selecting specific seminars from the comprehensive program of training courses offered by sartorius college on interpersonal communication, leadership and work techniques or by attending our sales and technical training courses .
sartorius combines its biotechnology division with the french - based biotech supplier stedim s. a. to enable their joint company sartorius stedim biotech to become a leading international technology provider to the biopharmaceutical industry. the new company is listed on the paris euronext stock exchange .
in 1947, erich sartorius suddenly died. he had been in a leading position within the company for 41 years. his son, horst sartorius, takes over the management of the company in a time which is characterized by the rebuilding after world war ii .
schoser bg, frosk p, engel ag, klutzny u, lochmuller h, wrogemann k. commonality of trim32 mutation in causing sarcotubular myopathy and lgmd2h. ann neurol. 2005 apr. 57 (4): 591 - 5. [ medline ] .
our employees receive bonuses in accordance with local standards. in addition, sartorius offers company paid contributions to health insurance and retirement plans .
sartorius combines its biotechnology division with the french - based biotech supplier stedim s. a. to enable their joint company sartorius stedim biotech to become a leading international technology provider to the biopharmaceutical industry. the new company is listed on the paris euronext stock exchange. official groundbreaking ceremony for a new plant in beijing. sartorius has now doubled its production capacity in china from roughly a former 4, 000 square meters to more than 8, 000 square meters (photo). sartorius acquires toha plast gmbh and strengthens its position in plastics technology for biopharmaceutical disposables. official groundbreaking ceremony for a new laboratory building: this enables sartorius to continue expanding r & d; capacities for the biotechnology division at its goettingen headquarters .
in january 2012, sartorius conducts its business operations in three new divisions: bioprocess solutions, lab products & services and industrial weighing. these new divisions each combine their respective businesses for the same customer groups and fields of application and thus more clearly reflect sartorius’ focus on its major markets .
alliance with nir online: sartorius is granted the right to sell and service near infrared spectroscopy systems for customers in the food and pharmaceutical industries .
the
combics
modular series of industrial scales and related equipment is launched. a new sartorius knowledge center is inaugurated in bangalore, india .
german chancellor gerhard schröder officially opens
plant 2001
for filter production in goettingen. this plant is the largest single investment ever made in sartorius’s corporate history. also, sartorius college, a conference center promoting the internal and external transfer of knowledge, is inaugurated in a festive ceremony .
eurex frankfurt ag uses cookies to improve its website. if you continue to browse our website, you agree with our use of cookies. for more details and how to manage cookies (i. e. to object web analytics), please see our privacy and cookies policy .
categories: europe stock alerts yahoo financeget full capitalcube analysis * disclaimer: this is as of previous day’s closing price. technical indicators below is a quick look at 5 technical indicators for sartorius ag. more studies are available on the technical chart. indicator signal closing price above / below 50 day moving average bearish closing price above / below 200 day moving average bearish 50... read more (read more... )
categories: europe stock alerts yahoo financeget full capitalcube analysis * disclaimer: this is as of previous day’s closing price. technical indicators below is a quick look at 5 technical indicators for sartorius ag. more studies are available on the technical chart. indicator signal closing price above / below 50 day moving average bullish closing price above / below 200 day moving average bearish 50... read more (read more... )
categories: europe stock alerts yahoo financeget full capitalcube analysis * disclaimer: this is as of previous day’s closing price. technical indicators below is a quick look at 5 technical indicators for sartorius ag. more studies are available on the technical chart. indicator signal closing price above / below 50 day moving average bullish closing price above / below 200 day moving average bullish 50... read more (read more... )
sartorius acquires the companies bio - outsource based in glasgow, scotland and cellca based in laupheim, germany. both acquisitions complement the process development portfolio .
we offer you a secure and pleasant environment so that you can fully concentrate on your tasks, maximize your full potential and come up with new, creative ideas. sartorius wants employees who show initiative and are willing to take on responsibility. in return, they can expect a lot from sartorius .
liewluck t, lovell tl, bite av, engel ag. sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a dnm2 mutation. neuromuscul disord. 2010 dec. 20 (12): 801 - 4. [ medline ]. [ full text ] .
sartorius acquires the companies intellicyt and virocyt, both based in the usa, to expand the portfolio of its lab products & services division into bioanalytics. with the acquisition of centrifuge specialist ksep systems, also headquartered in the usa, sartorius adds another innovative single - use technology to its bioprocessing product array .
tremendous international growth has been an integral part of the company history of sartorius ag for over 140 years: to date, 50 production and sales locations have been established. some 30 percent of sales are achieved in north america, 50% in emea and 20% in asia - pacific. this growth came with an increase in banking connections and bank accounts, in turn leading to soaring costs and a lack of visibility. sartorius’ challenge was to replace the great number of local treasury and payment systems with different technologies and to establish a global group treasury at their headquarters in göttingen, germany .
sartorius acquires the liquid handling segment of biohit, the finnish laboratory specialist. the group thus adds a key component to its product offering for laboratory instruments .
official groundbreaking ceremony for a new laboratory building: this enables sartorius to continue expanding r & d; capacities for the biotechnology division at its goettingen headquarters .
the international consulting company
frost & sullivan
confers the
2006 growth strategy leadership award
to sartorius for its successful market segment of moisture analyzers .
german chancellor gerhard schröder officially opens
plant 2001
for filter production in goettingen. this plant is the then largest single investment ever made in sartorius’ corporate history. also, sartorius college, a conference center promoting the internal and external transfer of knowledge, is inaugurated in a festive ceremony (photo) .
in bohemia, ny sartorius opens a new application center for the americas featuring the most advanced laboratory facilities and equipment for product tests, demonstrations and training sessions .
b. braun biotech international, the world’s leading manufacturer of fermenters, bioreactors and cell cultivation systems, is acquired (now sartorius stedim systems, photo) .
the foundation of the membrane filter company
membranfilter - gesellschaft m. b. h .
in goettingen in 1927 is another cornerstone in sartorius’ company history .
shanghai becomes home to the new asian sales and marketing headquarters of the sartorius group that manages all sales and marketing activities for china and for the entire asian region .
in autumn 2013, sartorius conducted its first group - wide employee survey. both the response rate and overall evaluation were clearly above those of comparable studies, underscoring the high engagement of sartorius staff. we plan to repeat the employee survey exercise at regular intervals in future to enable us to identify changes over time and investigate their significance .
sartorius acquires the liquid handling segment of biohit, the finnish laboratory specialist (photo). the group thus adds a key component to its product offering for laboratory instruments .
at sartorius, you will be working for a technology group that is represented in over 110 countries. openness to new ideas and the creativity to make them a reality are the cornerstones of our way of doing business. thanks to flat hierarchies and short decision - making channels, young professionals at sartorius can make a difference right from the start .
backed by over eight decades of experience in developing the best filtration technologies, sartorius offers you cutting - edge lab water systems designed to meet, and exceed, your quality standards .
sartorius expands its bioprocess portfolio by adding cell culture media: the company signs a long - term collaboration, supply and distribution agreement with the swiss - based life science group lonza .
sartorius has won the ‘best innovator 2005’ award in the category of ‘time to profit’ in a competition organised by management consultant a t kearney and the leading german - language business magazine wirtschaftswoche .
a new factory is opened in arvada, colorado: sartorius extends available capacity and now has a total area of some 6, 000 square meters (nearly 65, 000 square feet) .
sartorius receives the initiative prize for training and continuing education from the otto wolff foundation, the german chamber of commerce and industry and from the “wirtschaftswoche“, a german - language weekly financial journal .
at the recommendation of otto hahn (chemist and nobel prize winner in 1944 and president of the max - planck institute in goettingen), sartorius commences industrial - scale manufacture of hydrodynamic bearings .
mission: strongly rooted in the scientific and research communities and closely aligned with customers and technology partners, sartorius is dedicated to its philosophy of
turning science into solutions
every single day .
sartorius moved into the field of bioanalytics last year through the $ 90 million acquisition of cell - screening platform firm intellicyt. “with the essen real - time, live - cell analysis platform, we will add another key technology for advancing and accelerating drug discovery applications to our lab divisions’ portfolio, ” commented joachim kreuzburg, ph. d. , sartorius ceo. “this powerful technology offers important synergies with our intellicyt business. going forward, sartorius will be able to provide our customers the broadest and, we believe, the most innovative portfolio for cell analysis in the industry. ”
the industrial technologies division specializing in industrial weighing and control equipment is sold to the japanese group minebea co. , ltd. this now enables sartorius to focus on its core bioprocess and lab businesses .
at its headquarters in goettingen, germany, sartorius formally opens a new building with a floor space of 6, 000 square meters, or nearly 65, 000 square feet, for membrane manufacture .
official groundbreaking ceremony for a new plant in beijing. sartorius has now doubled its production capacity in china from roughly a former 4, 000 square meters to more than 8, 000 square meters .
experts who are at the top of their fields in science and technology work at sartorius, in interdisciplinary and, more often than not, international project teams. at the same time, they benefit from short decision - making paths and the family - style corporate culture at sartorius. we appreciate individual performance, give individuals considerable freedom in their work and foster an open exchange of experiences and ideas .
a. t. kearney, a global management consultancy, and “wirtschaftswoche”, a german weekly business news magazine, honor sartorius as the “best innovator in 2005” in the time - to - profit category .
sartorius receives the initiative prize for training and continuing education from the otto wolff foundation, the german chamber of commerce and industry and from the
wirtschaftswoche
, a german - language weekly financial journal .
regardless of whether you already have a clear idea of your career path or simply want to get a taste of what' s out there – sartorius puts a world of development opportunities at your feet .
sartorius is continuing to expand the bioanalytics portfolio of its laboratory products & services division by acquiring essen bioscience. this u. s. company is an innovation leader in cell analysis systems for medical drug research .
sartorius is one of the world' s leading international pharmaceutical and laboratory equipment providers. our innovative products and high - quality services help customers around the globe implement complex and quality - critical processes in biopharmaceutical ...
sartorius ag is a germany - based supplier of pharmaceutical and laboratory equipment. it operates through two segments: bioprocess solutions and lab products and services. the bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single - use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, and filter technology for clarification, among others. the lab products and services segment provides instruments, consumables and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation and membrane filter systems for sterility testing of parenterals .
as a total solution provider sartorius merges one of the broadest portfolios of single - use components, hybrid or traditional stainless steel systems and services. our integrated solutions cover fermentation and filtration as well as purification and fluid management .
together with the customer, sartorius developed an additional repeatability test, which is now performed as a supplement to dkd calibration. the test enables the measurement uncertainty to be more accurately calculated and, therefore, the quality of more
a. t. kearney, a global management consultancy, and
wirtschaftswoche
, a german weekly business news magazine, honor sartorius as the
best innovator in 2005
in the time - to - profit category .
sartorius is a leading international pharmaceutical and laboratory equipment supplier. with our innovative products and services, we are helping our customers across the entire globe to implement their complex and quality - critical biomanufacturing and laboratory processes reliably and economically .
in shanghai, china, sartorius opens a new application center featuring the most advanced laboratory facilities and equipment for product tests, demonstrations and training sessions. as a result, the company is strengthening its position on the asian market .
i particularly want to acknowledge the patience and assistance of lesley bretag in the lengthy preparation of this history. archivists at the universities of kansas and chicago; the marine biological laboratory, woods hole; the zeiss corporate archives, jena; the institute of plant sciences, graz; and s. karger, ag, basel; along with members of the gelfan, pool, and ling families have been especially generous in providing photographs and images .
facing the challenges in the development of suspension - based autologous cell therapies and manufacturing of personalized medicinal products using cell culture under gmp - conditions this study presents ways to overcome obstacles by employing the ambr 250 modular expansion system from sartorius .
there are a number of reasons that attract investors towards large - cap companies such as sartorius aktiengesellschaft (db: srt), with a market cap of €8. 47b. big corporations are much sought after byread more ...
sartorius stedim biotech andpenn state university have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. this long - term relationship will support the education and preparation of the next generation of biotechnology leaders. part o ...
sartorius stedim biotech andpenn state university have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. this long - term relationship will support the education and preparation of the next generation of biotechnology leaders. part o... more
richard zsigmondy, chemist and physicist as well as nobel prize laureate in 1925, invents the membrane filter in 1918 and the
cold ultrafilter”. these filters serve as the basis for commercial - scale production of sartorius separation and filter technology products .
as a partner for pharmaceutical and laboratory companies, sartorius is a global leader in dynamic sectors that will continue to grow for many years to come. our areas of core expertise are fermentation and filtration technologies, fluid management and purification for the manufacture of biopharmaceuticals, as well as laboratory instruments. natural scientists, engineers, business managers, you name it – at sartorius, experts of diverse fields work right along with our partners and customers who are among the best and brightest in their sector .
the siemens technology group andsartorius stedim biotech (ssb), a leading international supplier for the biopharmaceutical industry, have agreed on long - term cooperation in the area of automation. this agreement provides that sartorius stedim biotech will preferably use siemens automation t ...
the siemens technology group andsartorius stedim biotech (ssb), a leading international supplier for the biopharmaceutical industry, have agreed on long - term cooperation in the area of automation. this agreement provides that sartorius stedim biotech will preferably use siemens automation t... more
perfectly balanced – the tacta experience have you ever considered the overall user experience in pipetting? we have. sartorius proudly presents tacta, the new premium mechanical pipette with superb comfort and reliability. tacta makes pipetting effortless and safe, while producing accurate... more
-: 9 ‍months business performance of bioprocess solutions division in 2017 temporary weaker than expected ​. ‍key figures on 9 - month business development in 2017​. ‍full - year 2017 guidance adjusted​. ‍mid - term outlook and targets remain unchanged​. ‍for first nine months of 2017, sartorius group achieved revenue growth of 8. 6% in constant currencies to about 1. 04 billion euros​. ‍for first nine months of 2017, sartorius group achieved an underlying ebidta margin of 24. 8% versus 9 month 2016 25. 0% ​. ‍sartorius group now expects that sales revenue in constant currencies will increase by approx. 9% for full - year of 2017​. ‍underlying ebidta margin in constant currencies now projected to reach approx. prior - year level of around 25. 0% for fy 2017​ .
sartorius relocates its single - use bag manufacture from california to puerto rico; covering an area of 5, 000 square meters, or 53, 820 square feet, the new eco - friendly building complex for manufacturing filters and aseptic bags is officially opened (photo) .
langley, j. n. : on contraction of muscle chiefly in relation to the presence of ‘receptive substances. ’ part iv. the effect of curari and some other substances on the nicotine response of the sartorius and gastrocnemius muscles of the frog. j. physiol .
small - cap and large - cap companies receive a lot of attention from investors, but mid - cap stocks like sartorius aktiengesellschaft (fra: srt), with a market cap of €7. 89b, are often out of the spotlight. read more ...
in 1916, richard zsigmondy together with wilhelm bachmann invents the membrane filter. the invention is patented under the publication number de 329060 c. with this groundbreaking work in cooperation with the
sartorius - werke
, zsigmondy laid the foundation for germany’s leading role in membrane technology .
the founder of the company, florence sartorius sr. , passed away in 1925. since two of his sons, julius and florence jr. , had died in 1918, the responsibility for the company went over to the shoulders of wilhelm as commercial and erich as technical director .
sartorius works for sectors that are required to meet high quality and safety standards. close relationships with customers as our partners are therefore the foundation of our business. such bonds built upon trust are more important to us than short - term profits. by collaborating closely with scientific institutes and universities, sartorius remains at the forefront of the latest developments and, as a technology leader, sets the standards in many market segments. in fact, ever since it was founded, our company has always fostered open exchange with the scientific community, helping it to move forward .
on this event sartorius and bd jointly focused with experts from the industry on sterility testing of drug products - challenges for quality departments. international experts from the pharmaceutical and biotech industry and the national regulatory & safety institutes covered topics of high interest around quality control, development, production and inspection .
sartorius is investing in its research and development and in its sales structures, as well as further expanding its portfolio through alliances and acquisitions to continue to grow sustainably and profitably in the future as well. at the focus of these activities are the high - growth markets in north america and asia .
sartorius looks back on a successful first quarter 2018 .
both divisions started off the year strongly in line with our expectations and further increased their revenues in the first quarter of 2018 in all regions. on the currency side, however, we faced some headwinds, especially due to th ...
sartorius looks back on a successful first quarter 2018 .
both divisions started off the year strongly in line with our expectations and further increased their revenues in the first quarter of 2018 in all regions. on the currency side, however, we faced some headwinds, especially due to th... more
we look for people with leadership personalities who think beyond department cubicles and country borders and who will actively join us in growing our business in international markets. to help you hone your skills for developing your personal career, you can choose the right program from the comprehensive offering of further training courses held at sartorius college .
not interested (anymore) in working at a little job in a big company? if you do not like being just one of the nondescript masses who are responsible for taking care of small details, then sartorius is the right place for you. we expect you to think on your own, take the initiative and be willing to assume responsibility. rigid hierarchies and long - drawn - out decision - making processes are not our thing at sartorius. instead, we see and appreciate individual performance and give each employee lots of space to develop. with us, you can realize your full potential to promote our company’s growth and your personal career .
a growing number of medications are biopharmaceuticals. these are produced using living cells in complex, lengthy and expensive procedures. the bioprocess solutions division provides the essential products and technologies to accomplish this. in fact, sartorius has been pioneering and setting the standards for single - use products that are currently used throughout all biopharmaceutical manufacturing processes .
typical mri findings in the thigh include involvement of the adductor magnus, sartorius, and quadriceps group, except for the rectus femoris, which is spared along with the adductor longus and gracilis. in the calf, involvement of the soleus, lateral gastrocnemius, and peroneal group is observed, with sparing of the tibialis anterior. [ 2 ]
long - term relationships, enjoyment shared while working together, exchange of ideas as equals – all this is also part of everyday work inside sartorius. it is no surprise that the strong identification of sartorians with their company is a common thread woven throughout its history. in germany, for instance employees stay with us around 14 years on average .
a healthy company needs healthy employees. company - wide health management is not an obligation, but rather a matter of heart for us. depending on site locations, we offer a range of comprehensive health screening benefits, medical check - ups, consulting services and concrete occupational safety measures. we take care of everything to ensure healthy working conditions, as safety and health have top priority at sartorius. as an industrial corporation, occupational safety is a major focal point at sartorius. we are continuously improving technical and organizational working conditions to keep the number of work - related medical conditions, health hazards and accident risks as low as possible. we achieve this through technical improvements and regular training courses .
in several countries, sartorius organizes company sports events to encourage healthy lifestyles. by taking part in one of the numerous company sports groups, colleagues also get a
sporting chance
to get to know each other and stay fit together. whether playing soccer, sailing or jogging in a group, the main focus is the enjoyment of exercising together .
sartorius has evolved from a small workshop for mechanical instruments into an international group of high - tech companies with more than 6, 200 employees. yet our multinational corporation has retained the essence of what defines us as a group: close cooperation with our customers and alliance partners, our cosmopolitan outlook, regional roots and a people - focused corporate culture .
sartorius has agreed buy cell - based assay and instrumentation firm essen bioscience from its private equity owner sfw capital partners for $ 320 million cash. essen develops instruments, software, and reagents for live - cell imaging and data analysis. the firm’s flagship incucyte ® platform for real - time, quantitative live - cell imaging and analysis was launched in 2006 .
sartorius operates at the forefront of science and technology. at our company, products take shape that didn’t even exist a few years back. moreover, we place the highest requirements on our product quality. this is our mission that also serves as a guiding principle for our managers. it is their duty to lead their own unit to achieve top performance .
combined systems: the arium® comfort systems are the highlights of the new sartorius family of lab water systems for turning tap water into pure and ultrapure water. featuring the most advanced purification technologies, these systems deliver both astm type i and type iii water all in one unit, or both astm type i and type ii, depending on the version you select .
are you studying engineering, natural sciences, business or information systems management and looking for an interesting internship? sartorius can offer you interesting internships in all company departments, such as in research & development, quality management, sales, marketing, corporate communications, hr or it. even as an intern, we integrate you into ongoing projects and our day - to - day operations .
with ideas, expertise and a passion to excel, our employees contribute immensely to the success of our company. we empower them to use their skills to their fullest potential. we offer motivating work conditions, comprehensive training seminars, and flextime work schedules. innovative and dynamic, international and family - style, with strong values and roots: working at sartorius is something really special .
the basis of your career is your professional expertise. you enjoy working with professionalism, constantly learning new things and thinking outside the box. then you will fit in well at sartorius. as a supplier and partner of pharmaceutical and biotech companies, we are a global leader in highly dynamic sectors that will continue to grow for many years to come. this means that the demand for new technologies will steadily increase in the future as well. to meet such growing requirements, we are looking for people who would like to shape new developments. at sartorius you will be working at the cutting edge of science and technology, on products that didn’t even exist a few years back – and with colleagues, partners and customers who are among the best in their field .
as a partner of the pharmaceutical and laboratory industries, sartorius is a global leader in the dynamic sectors of the future: staying abreast of evolving technologies and leading changes are part of our daily “bread and butter” business. so this is why we look for managers who will lead change, instead of just following it. being open - minded to new ideas and approaches is among our most important values .
sartorius’ main reason for choosing bellin was the option to integrate all group companies worldwide in the treasury setup via the central platform tm5. the system was first rolled out in germany with a consolidation of payments; these are now processed entirely via ebics. this was followed by the integration of the french group companies with payments processed via global ebics. once all entities in mainland europe had been integrated in tm5, the asia - pacific region and the uk were incorporated. currently, cce countries are being included with host - to - host connections to two main banks. the treasury team trained all group companies in all regions, one country after another, offering onsite training. from a technological point of view, sartorius uses three different payment solutions but the user interface is the same for everyone. sartorius has implemented cash pools in europe and is in the process of doing the same in north america and asia - pacific. they’re also planning a payment factory. liquidity forecasting is done centrally at headquarters for the entire group and göttingen is also responsible for fx hedging and controlling global payments. having implemented tm5 and benefiting from a more efficient and integrated treasury has also helped strengthen the group identity in all units .
born in oklahoma, he was adopted and raised in virginia. his social media is managed by his mother. his mom has appeared in his vine videos. he has an older sister named caroline, and a cat named prince. his birth name is rolf jacob sartorius. rolf is also the name of his father and grandfather. in late 2017, he began dating stranger things star millie bobby brown .
sartorius stedim biotech (ssb) is delighted to announce that its royston site (formerly tap biosystems), has won two prestigious awards at the annual cambridge regional college apprenticeship dinner held in march. chosen as category winners for the science, technology, engineering and mathematics (stem) apprenticeships, the company also won “overall employer of the year”, selected from over 800 local employers also offering apprenticeships with the college .
assistant principal for employer engagement at cambridge regional college, paul skitt stated: “we are delighted to award sartorius stedim biotech our overall employer of the year award for 2016. they have shown an outstanding commitment to apprenticeships over the past three years, working closely with cambridge regional college to help their apprentices achieve at an extremely high level. we congratulate them whole - heartedly on winning this well - deserved award. ”
“as a leading pharmaceutical and laboratory equipment supplier, we are well aware of the challenges of translating research findings into clinical practice, ” stated michael melingo, member of the group executive committee and president of the lab products & services division at sartorius. “with this forum, we aim to offer our customers and all those engaged in this field a platform for entering into a dialog and to accelerate this translation process. ”
with the expert career path program, sartorius offers its employees in the research and development unit a structured, transparent approach to their career development. like a manager‘s career, an expert career covers defined steps up the career ladder, enabling an expert to be promoted several rungs. as a result, experts can focus on the core areas of their work – developing products and driving innovations, without being sidetracked by management tasks .
sartorius offers its employees all the benefits of a large group: the enjoyment of working in an international environment, a comprehensive and progressive human resources development policy, attractive compensation and, last but not least, the flexibility to enable them to set their work hours to suit their lifestyles. at the same time, they enjoy all the benefits of a medium - sized company: short decision - making chains and fast lines of communication .
are you looking to gain practical experience, but don’t want to take time off from your studies? if that’s the case, you can work for us as a long - term student trainee alongside your studies and reap double the benefits: you gain key professional experience while earning some money on the side. the reduced number of weekly working hours (usually 10 to 20 a week) let you continue to concentrate on your degree while working at sartorius .
out of the work from this period, it is my opinion that the contribution of taylor and whitaker (1927) presents us with the definitive invention of the intracellular glass micropipette electrode. for their intracellular reference electrodes in this particular study, they had used sharp, agar - saturated kcl - filled barber micropipettes. by using saturated kcl rather than ringer solution or low concentrations of nacl or kcl, as others had done, they greatly reduced the internal resistance of their electrodes and largely eliminated the junction potential between their electrodes and whatever solution they were inserted into, e. g. sea water, pond water, cell sap, or protoplasm. they also used ag / agcl 2 nonpolarizable junctions for connection to their electrical circuits. it seems quite strange that this remarkable combination of features was neither emphasized by taylor and whitaker in their paper nor utilized by others for more than 20 years .
connecting the dots between university research and implementation in industrial manufacture: research xchange forum hosted by the international pharma and laboratory supplier sartorius will take place on 22 - 23rd february 2017, in goettingen, germany. this industry platform that addresses scientists and staff from academic research institutes and industry will be dedicated entirely to oncology. keynote presentations given by internationally recognised scientists and representatives from research and development will provide insights into the latest developments of their specific cancer research and therapy approaches .
progress in oncology is particularly based on excellent collaboration between drug discovery and applied research. “we are consistently implementing a number of measures to enable researchers to reach these goals faster by breakthrough innovations, such as the new cell analysis platform for immuno - oncology, which has been integrated into the sartorius portfolio following the acquisition of intellicyt, ” stated terry dunlay, who heads the bioanalytics unit. this is also reflected in the subjects that will be covered by the scientific forum.
the sartorius group is an international pharmaceutical and laboratory equipment supplier , covering the segments of bioprocess solutions and lab products & services . in 2014 , the technology group earned sales revenue of 891.2 million euros ( 2013 : 791.6 ) . founded in 1870 , the göttingen-based company currently employs around 5,600 persons . 
the sartorius group is an international pharmaceutical and laboratory equipment supplier, covering the segments of bioprocess solutions and lab products & services. in 2014, the technology group earned sales revenue of 891.2 million euros (2013: 791.6). founded in 1870, the göttingen-based company currently employs around 5,600 persons.
the sartorius group is an international pharmaceutical and laboratory equipment supplier, covering the segments of bioprocess solutions and lab products & services. in 2014, the technology group earned sales revenue of 891.2 million euros (2013: 791.6). founded in 1870, the göttingen-based company currently employs around 5,600 persons.